NASDAQ: ASRT
Assertio Holdings Inc Stock Forecast, Predictions & Price Target

Analyst price target for ASRT

Based on 2 analysts offering 12 month price targets for Assertio Holdings Inc

Min Forecast
$18.00-2.54%
Avg Forecast
$18.00-2.54%
Max Forecast
$18.00-2.54%

Should I buy or sell ASRT stock?

Based on 2 analysts offering ratings for Assertio Holdings Inc.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
2 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ASRT stock forecasts and price targets.

ASRT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-04-09
lockedlocked$00.00+00.00%2026-04-09

1 of 1

Forecast return on equity

Is ASRT forecast to generate an efficient return?

Company
36.6%
Industry
56.68%
Market
166.28%
ASRT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ASRT forecast to generate an efficient return on assets?

Company
12.88%
Industry
18.82%
ASRT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ASRT earnings per share forecast

What is ASRT's earnings per share in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
-$0.18
Avg 2 year Forecast
$2.01
Avg 3 year Forecast
$6.45

ASRT revenue forecast

What is ASRT's revenue in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$115.9M-2.34%
Avg 2 year Forecast
$132.5M+11.6%
Avg 3 year Forecast
$150.0M+26.36%
ASRT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ASRT revenue growth forecast

How is ASRT forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
8.05%
Industry
8.37%
Market
14.06%
ASRT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ASRT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ASRT vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
ASRT$18.47$18.00-2.54%Hold
KALA$0.11N/AN/A
CRDL$1.37$8.50+520.44%Strong Buy
DERM$5.19$13.00+150.48%Buy
CTOR$0.95N/AN/A

Assertio Holdings Stock Forecast FAQ

Is Assertio Holdings Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: ASRT) stock is to Hold ASRT stock.

Out of 2 analysts, 0 (0%) are recommending ASRT as a Strong Buy, 0 (0%) are recommending ASRT as a Buy, 2 (100%) are recommending ASRT as a Hold, 0 (0%) are recommending ASRT as a Sell, and 0 (0%) are recommending ASRT as a Strong Sell.

If you're new to stock investing, here's how to buy Assertio Holdings stock.

What is ASRT's earnings growth forecast for 2026-2028?

(NASDAQ: ASRT) Assertio Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 14.14%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.37%.

Assertio Holdings's earnings in 2026 is -$30,375,000.On average, 6 Wall Street analysts forecast ASRT's earnings for 2026 to be -$1,134,348, with the lowest ASRT earnings forecast at -$5,242,494, and the highest ASRT earnings forecast at $4,195,800. On average, 5 Wall Street analysts forecast ASRT's earnings for 2027 to be $12,972,820, with the lowest ASRT earnings forecast at $1,515,902, and the highest ASRT earnings forecast at $30,927,105.

In 2028, ASRT is forecast to generate $41,548,086 in earnings, with the lowest earnings forecast at $39,918,749 and the highest earnings forecast at $42,770,088.

What is ASRT's revenue growth forecast for 2026-2028?

(NASDAQ: ASRT) Assertio Holdings's forecast annual revenue growth rate of 8.05% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 8.37%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.06%.

Assertio Holdings's revenue in 2026 is $118,713,000.On average, 6 Wall Street analysts forecast ASRT's revenue for 2026 to be $747,187,515, with the lowest ASRT revenue forecast at $695,755,130, and the highest ASRT revenue forecast at $798,555,448. On average, 5 Wall Street analysts forecast ASRT's revenue for 2027 to be $853,854,929, with the lowest ASRT revenue forecast at $765,814,030, and the highest ASRT revenue forecast at $923,140,410.

In 2028, ASRT is forecast to generate $966,838,602 in revenue, with the lowest revenue forecast at $928,941,055 and the highest revenue forecast at $995,261,762.

What is ASRT's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: ASRT) forecast ROA is 12.88%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 18.82%.

What is ASRT's Price Target?

According to 2 Wall Street analysts that have issued a 1 year ASRT price target, the average ASRT price target is $18.00, with the highest ASRT stock price forecast at $18.00 and the lowest ASRT stock price forecast at $18.00.

On average, Wall Street analysts predict that Assertio Holdings's share price could fall to $18.00 by Apr 9, 2027. The average Assertio Holdings stock price prediction forecasts a potential downside of 2.54% from the current ASRT share price of $18.47.

What is ASRT's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: ASRT) Assertio Holdings's current Earnings Per Share (EPS) is -$4.74. On average, analysts forecast that ASRT's EPS will be -$0.18 for 2026, with the lowest EPS forecast at -$0.81, and the highest EPS forecast at $0.65. On average, analysts forecast that ASRT's EPS will be $2.01 for 2027, with the lowest EPS forecast at $0.24, and the highest EPS forecast at $4.80. In 2028, ASRT's EPS is forecast to hit $6.45 (min: $6.19, max: $6.64).

What is ASRT's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: ASRT) forecast ROE is 36.6%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.